Clonal spread of carbapenem resistant Pseudomonas aeruginosa in an University Hospital

Tunisie Medicale

Volumn 86, Issue 7, 2008, Pages 653-656

  Hammami, Samia ^a   Ghozzi, Rafiâa ^a   Ben Ayed, Salima ^a   Ben Hassen, Assia ^a   Ben Redjeb, Saida ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

pid mie; Pseudomonas aeruginosa; R sistance aux carbap n mes

Indexed keywords

BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEFTAZIDIME PLUS CLAVULANATE; CLOXACILLIN; COLISTIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; TICARCILLIN; TIMENTIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME ASSAY; ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; SEROEPIDEMIOLOGY; SEROTYPING; STAPHYLOCOCCUS AUREUS; TUNISIA; UNIVERSITY HOSPITAL; MULTIDRUG RESISTANCE; PSEUDOMONAS INFECTION;

ANTI-BACTERIAL AGENTS; CARBAPENEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS, UNIVERSITY; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 67649204868     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Dubois V, Arpin C, Melon M, Et Al. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: Efficacy of cefepime-amikacine therapy and analysis of β-lactam resistance. J Clin Microbiol 2001; 39: 2072-2078. (Pubitemid 32531461)
2. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing-Fifteenth Informational Supplement: Approved standard M2-A8 and M7-A6. NCCLS, Wayne, Pensylvania, USA, 2005.
3. Yan Jj, Wu Jj, Tsai Sh, Chuang Cl. Comparaison of the double-disk, combined disk, and Etest methods for detection metallo-β-lactamase in gram- negative bacilli. Diag Microbiol Infect Dis 2004; 49: 5-11.
4. Cambell M, Mahenthiralingam E, Speert DP. Evaluation of Random amplified polymorphic DNA typing of Pseudomonas aeruginosa. J Clin Microbiol 2000; 38: 4614-4615 (Pubitemid 32244557)
5. Tassios Pt, Gennimata V, Manlatis An, et al. Emergence of multidrug resistant in ubiquitous and dominant Pseudomonas aeruginosa serogroup O11. J Clin Microbiol 1998; 36: 897-901. (Pubitemid 28146265)
6. Tenover Fc, Arbeit Rd, Goering Rv, et al. Guest commentary: Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
7. Cornaglia G, Mazzriol A, Lauretti L, Rossolini Gm, Fontana R. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase. Clin Infect Dis 2000; 31: 119-1125.
8. Di Martino P, Gagniere H, Bery H, Brat L. Antibiotic resistance and virulence properties of Pseudomonas aeruginosa strains from mechanically ventilated patients with pneumonia in intensive care units: comparaison with imipenem-resistant extra-respiratory tract isolates from uninfected patients. Microb Infect 2002; 4: 613-620. (Pubitemid 34607411)
9. Cavallo Jd, Plesiat P, Bebar C, et al. Evolution de la résistance aux antibiotiques de Pseudomonas aeruginosa en France de 1994 à 1998. Lett infect 2000; 15: 18-23.
10. Cattoen C, Levent Tt, Grandbastien B, et al. Observatoire régional Pseudomonas aeruginosa du Nord Pas de Calais : Données épidémiologiques et microbiologiques. Med Mal Infect.1999; 29: 160-166. (Pubitemid 29492996)
11. Deplano A, Denis O, Poirel L, et al. Molecular Characterization of an epidemic clone of panantibiotic-resitant Pseudomonas aeruginosa. J Clin Microbiol 2005; 43: 1198-1204. (Pubitemid 40364938)
12. Lee K, Lee Wg, Uh Y, Et Al. Vim- And Imp- type metallo-β-lactamase- producing Pseudomonas Spp and Acinetobacter Spp in Korean hospitals. Emerg Infect Dis 2003; 9: 868-871.
13. Toleman Ma , Biedenbach D, Bennett Dmc, Jones Rn ,Walsh Tr. Italien metallo-β-lactamases: a national problem? Report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother 2005; 55: 61-70. (Pubitemid 40192615)
14. Martinez Lm, Pascual A, Conejo Mdc, Picabea L , Perea EJ. Resistance of Pseudomonas aeruginosa to imipenem induced by eluates from siliconized latex urinary catheters is related to outer membrane protein alterations. Antimicrob Agents Chemother 1999; 43: 397-399. (Pubitemid 29079183)
15. Pai H, Kim Jw, Kim J, Lee Jh, Choe Kw, Gotoh N. Carbapenem resistance mechanism in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 2001; 45: 480-485.
16. Tsakaris A, Pournaras S, Woodford N, et al. Outbreak of infections caused by Pseudomonas aeruginosa producing Vim-1 carbapenemase in Greece. J Clin Microbiol 2000; 38: 1290-1292. (Pubitemid 30140608)
17. Sasaki M, Hiyama E, Takesue Y, Kodaira M, Sueda T, Yokoyama T. Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japenese hospiatal. J Hosp Infect 2004; 56: 111-118. (Pubitemid 38155272)
18. Bingen E, Bonacorsi S, Rohrlich P, et al. Molecular epidemiology provides evidences of genotypic heterogenity of multidrug-resistant Pseudomonas aeruginosa serotypes O12 outbreak isolates from a pediatric hospital. J Clin Microbiol 1996; 34: 3226-3229. (Pubitemid 26389389)
19. Renders N, Romling U, Verbrugh H, Belkum AV. Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA of macrorestriction fragments. J Clin Microbiol 1996; 34: 3190-3195. (Pubitemid 26389380)
20. Campbell M, Mahentiralingham E, Speert Dp. Evaluation of Random amplified polymorphic DNA typing of Pseudomonas aeruginosa. J Clin Microbiol 2000; 38: 4614-4615. (Pubitemid 32244557)
21. Boutiba-Ben Boubaker I, Boukadida J, Triki O, Hannachi N, Ben Redjeb S. Epidémie d'infections urinaires nosocomiales à Pseudomonas aeruginosa multirésistant aux antibiotiques. Path Biol 2003; 51: 147-150.
22. Bert F, Bruneau B, Lambert-Zechovsky N, Branger C. Etude épidémiologique de la sensibilité aux antibiotiques de Pseudomonas aeruginosa. Path Biol 1994; 42: 491-497. (Pubitemid 24240386)
23. Vachee A, Schefelt Jm, Hussen Mo, Izard D, Ross P, Monteil H. Etude tricentrique de la sensibilité des sérotypes de Pseudomonas aeruginosa aux β-lactamines et aux aminosides. Path Biol 1997; 45: 357-362. (Pubitemid 27293351)
24. Salauze B, Badaoui H, Gholizadeh Y, Bossier B. Epidémie d'infection nosocomiale à Pseudomonas aeruginosa de sérotype O11 multiresistant. Med Mal Infect 1997; 24: 658-662.
25. Carmeli Y, Troillet N, Eliopoulos Mg, Samore Mh. Emergence of antibiotic resistant Pseudomonas aeruginosa comparaison of risks of antibiotic resistant with different anti-pseudomonal agents. Antimicrob Agents Chemother 1999; 43: 1379-1382.